Bolwell B - Search Results

1

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation.

Malik S, Bolwell B, Rybicki L, Copelan O, Duong H, Dean R, Sobecks R, Kalaycio M, Sweetenham J, Pohlman B, Andresen S, Tench S, Koo A, Figueroa P, Copelan E. Malik S, et al. Among authors: bolwell b. Bone Marrow Transplant. 2011 Dec;46(12):1519-25. doi: 10.1038/bmt.2010.336. Epub 2011 Jan 24. Bone Marrow Transplant. 2011. PMID: 21258422

2

Incidence of mixed chimerism using busulfan/cyclophosphamide containing regimens in allogeneic bone marrow transplantation.

Fishleder AJ, Bolwell B, Lichtin AE. Fishleder AJ, et al. Among authors: bolwell b. Bone Marrow Transplant. 1992 Apr;9(4):293-7. Bone Marrow Transplant. 1992. PMID: 1350939

3

G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.

Bolwell BJ, Fishleder A, Andresen SW, Lichtin AE, Koo A, Yanssens T, Burwell R, Baucco P, Green R. Bolwell BJ, et al. Bone Marrow Transplant. 1993 Dec;12(6):609-14. Bone Marrow Transplant. 1993. PMID: 7511016 Clinical Trial.

4

Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.

Bolwell BJ, Goormastic M, Yanssens T, Dannley R, Baucco P, Fishleder A. Bolwell BJ, et al. Bone Marrow Transplant. 1994 Dec;14(6):913-8. Bone Marrow Transplant. 1994. PMID: 7536072 Clinical Trial.

5

Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.

Kalaycioglu M, Copelan E, Avalos B, Klein J, Goormastic M, Bolwell B. Kalaycioglu M, et al. Among authors: bolwell b. Bone Marrow Transplant. 1995 Jan;15(1):105-10. Bone Marrow Transplant. 1995. PMID: 7742742

6

Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.

Bolwell BJ. Bolwell BJ. Semin Oncol. 1994 Aug;21(4 Suppl 7):86-95. Semin Oncol. 1994. PMID: 7916488 Review.

7

Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.

Kalaycioglu ME, Bolwell BJ. Kalaycioglu ME, et al. Among authors: bolwell bj. Bone Marrow Transplant. 1994 Jul;14(1):113-5. Bone Marrow Transplant. 1994. PMID: 7951097

8

HLA class II DNA typing and subsequent transplantation of an aplastic anemia patient using hair follicles as a DNA source.

Cook DJ, Li TC, Bolwell BJ. Cook DJ, et al. Among authors: bolwell bj. Bone Marrow Transplant. 1994 Sep;14(3):463-5. Bone Marrow Transplant. 1994. PMID: 7994274

9

High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancer.

Kalaycioglu ME, Lichtin AE, Andresen SW, Tuason L, Bolwell BJ. Kalaycioglu ME, et al. Among authors: bolwell bj. Am J Clin Oncol. 1995 Dec;18(6):491-4. doi: 10.1097/00000421-199512000-00007. Am J Clin Oncol. 1995. PMID: 8526191 Clinical Trial.

10

Outpatient bone marrow harvest: the Cleveland Clinic experience.

Bolwell BJ, Maurer W, Anderson J, Dannley R, Goormastic M, Zgrabik J, Sands K, Lichtin A, Andresen S, Pohlman B. Bolwell BJ, et al. Bone Marrow Transplant. 1995 Nov;16(5):703-5. Bone Marrow Transplant. 1995. PMID: 8547868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters